Alaunos Therapeutics
TCRT
29 hedge funds and large institutions have $204K invested in Alaunos Therapeutics in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
0% more funds holding
Funds holding: 29 → 29 (0)
5.05% less ownership
Funds ownership: 5.42% → 0.37% (-5.1%)
43% less capital invested
Capital invested by funds: $361K → $204K (-$156K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$3.45K |
| 2 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
+$3.11K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$506 |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$485 |
| 5 |
Morgan Stanley
New York
|
+$468 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$38K |
| 2 |
Two Sigma Investments
New York
|
-$31K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$29.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$8.19K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.27K |
TCRT Hedge Fund Activity: Q2 2026 in Review
29 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q2 2026, worth a combined $204K — down 43% from $361K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new TCRT positions and 4 closed out — a net gain of 2 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $3.45K. The largest seller was HRT Financial, exiting entirely with an estimated $38K sold.
- 29 institutional investors held Alaunos Therapeutics (TCRT) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $204K of Alaunos Therapeutics stock for Q2 2026, down 43% quarter-over-quarter.
- 6 funds opened new Alaunos Therapeutics positions in Q2 2026 and 4 closed out, a net change of +2 holders.
- The largest Alaunos Therapeutics buyer in Q2 2026 was Citadel Advisors, an estimated $3.45K added.
- The largest Alaunos Therapeutics seller in Q2 2026 was HRT Financial, an estimated $38K sold.
Based on aggregated 13F filings for Q2 2026.